Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

AGRONOMICS LIMITED Net Asset Value 2024

Feb 9, 2024

7474_nav_2024-02-09_6133092d-4958-4f67-b58e-f21e16867f03.html

Net Asset Value

Open in viewer

Opens in your device viewer

National Storage Mechanism | Additional information

RNS Number : 5652C

Agronomics Limited

09 February 2024

9 February 2024

Agronomics Limited

("Agronomics" or the "Company")

Net Asset Value calculation as at 31 December 2023

Agronomics Limited (AIM:ANIC), the leading listed company focused on the field of cellular agriculture, announces that its unaudited Net Asset Valuation ("NAV") per share calculation as at closing on 31 December 2023 was 16.90 pence per share, a 2.5% increase from 16.48 pence per share at 30 September 2023. Net Assets were £168 million, including investments of £146 million and uninvested cash and short-term deposits of £22 million. During the period, no fees were payable or accrued relating to the Shellbay Investments Limited Agreement.

The share price of 9.50 pence at the 31 December 2023 close represented a discount of 44% to the 31 December 2023 NAV per share. The average discount to the prevailing NAV per share over the last 12-month period was 34%. Under IFRS, the Company's unquoted investments are generally carried at cost or the most recent priced funding round.

Jim Mellon, Chair of Agronomics, commented:

Agronomics has a healthy balance sheet entering into 2024 and intends to preserve the majority of its capital for follow-on investments into its existing portfolio companies to assist with the achievement of major milestones such as regulatory approvals, product launches, or building out their commercial facilities. The Company continues to monitor and review new and emerging technologies within the field of cellular agriculture and will also look to expand the portfolio for further diversification should the opportunity arise.

Financing

During the period, 2,210 new ordinary shares were issued following the exercise of warrants. Gross proceeds of £660 were received by the Company.

The Board approved a share buyback programme for an aggregate amount of up to £3m for a period of 6 months commencing on 2nd October 2023.  To the period ending 31 December 2023, the Company has yet to initiate any buybacks.

Investment review

During the 3-month period, the Company had two positive revaluations and saw the portfolio companies receive government support and form new strategic partnerships:

·    9 October 2023, portfolio company BlueNalu closed a US$ 33.5 million Series B round led by NEOM with a US$ 20 million investment. The investment was accompanied by the signing of a Memorandum of Understanding with BlueNalu for the commercialisation, marketing and distribution of BlueNalu's cultured seafood.

·    16 November 2023, portfolio company Solar Foods closed an €8 million Series B financing round through the Finnish-based investment organiser Springvest.

·    1 December 2023, portfolio company Liberation Labs secured a US$ 25 million loan for its biomanufacturing facility in Richmond, Indiana. The loan was awarded by Ameris Bank which received a loan guarantee from the USDA as part of its "Business and Industry" loan guarantee program.

·    5 December 2023, portfolio company Clean Food Group was awarded government funding towards a £1 million project to accelerate novel low-emission food production systems.

Unaudited to 31 December 2023

£
Current Assets
Investments 145,879,692
Uninvested cash and deposits 22,007,344
Trade and other receivables 142,258
Current Liabilities
Trade and other creditors (203,046)
Net Assets 167,826,248
Capital and Reserves
Share capital 993
Share premium 134,482,024
Share reserve 1,686,336
Retained earnings 31,656,895
Net assets 167,826,248
Shares in Issue 993,154,244
Net Asset Value per share 16.90 pence

The quoted investments within the portfolio are valued under IFRS at bid price.

This announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) No. 596/2014, as it forms part of UK Domestic Law by virtue of the European Union (Withdrawal) Act 2018. Upon the publication of this announcement, this inside information is now considered to be in the public domain.

ENDS

For further information please contact:

Agronomics Limited Beaumont Cornish Limited Canaccord Genuity Limited Cavendish Securities Plc Peterhouse Capital Limited SEC Newgate
The Company Nomad Joint Broker Joint Broker Joint Broker Public Relations
Jim Mellon

Denham Eke
Roland Cornish

James Biddle
Andrew Potts

Harry Pardoe

Alex Aylen (Head of Equities)
Giles Balleny

Michael Johnson
Lucy Williams

Charles Goodfellow
Bob Huxford

Anthony Hughes
+44 (0) 1624 639396

[email protected]
+44 (0) 207 628 3396 +44 (0) 207 523 8000 +44 (0) 207 397 8900 +44 (0) 207 469 0936 [email protected]

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

NAVUPUQCPUPCPPR